Skip to main content

Table 3 Clinical Outcomes

From: The clinical relevance of luteal phase progesterone support in true natural cycle cryopreserved blastocyst stage embryo transfers: a retrospective cohort study

  Progesterone Supplementation (n = 149) No Progesterone Supplementation (n = 80) Unadjusted Statistics (p value and risk ratio*) Age-Adjusted Statistics
Positive hCG 93 (62.4%) 46 (57.5%) 0.5039
1.08 (0.86, 1.37)
0.5965
1.07 (0.84, 1.35)
Clinical pregnancy 75 (50.3%) 38 (47.5%) 0.6592
1.07 (0.80, 1.42)
0.7483
1.05 (0.79,1.39)
Miscarriage / Abortion 8 (5.4%) 2 (2.5%) 0.2918
2.21 (0.51, 9.68)
0.2622
2.33 (0.53, 10.24)
Ectopic pregnancy 0 (0.0%) 1 (1.3%) 0.3493 (no further modeling)
Multifetal gestation 11 (7.4%) 3 (3.8%) 0.2835
1.98 (0.57, 6.95)
0.3166
1.87 (0.55, 6.36)
Ongoing Pregnancy 73 (49.0%) 38 (47.5%) 0.7871
1.04 (0.78, 1.39)
0.8738
1.01 (0.76, 1.34)
  1. Values are total number (%) or p-value and age-adjusted risk ratio with 95% CIs